Skip to main content
SpringerLink
Log in

Clindamycin/Tretinoin

Clindamycin Phosphate/Tretinoin Gel

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Connetics Corporation. Connetics Licenses Velac(R) Gel From Yamanouchi. Media Release: 14 May 2002. Available from URL: http://www.connetics.com

    Google Scholar 

  2. Connetics Corporation. Connetics Announces Positive Results from Velac Phase III Pivotal Trials. Media Release: 23 Mar 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  3. Connetics Corporation. Connetics Affirms Velac Patent Position. Media Release: 22 Nov 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  4. Connetics Corporation. Connetics’?New Drug Application for Velac(R) Has Been Accepted for Filing by the FDA. Media Release: 25 Oct 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  5. Connetics Corporation. Connetics Presents 11 Scientific Posters at American Academy of Dermatology’s 62nd Annual Meeting. Media Release: 6 Feb 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  6. van Hoogdalem EJ, Terpstra IJ, Spiegel-Melsen D. Absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. European Journal of Clinical Pharmacology 52 (Suppl.): 152, 1997

    Google Scholar 

  7. Richter JR, Bousema MT, De Boulle KLVM. Efficacy of a fixed clindamycin phosphate 1.2%, tretinoin 0.025% gel formulation (Velac) in the topical control of facial acne lesions. Journal of Dermatological Treatment 9: 81–90, Jun 1998

    Article  CAS  Google Scholar 

  8. Zouboulis ChC, Derumeaux L, Decroix J, et al. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac Rm) applied once daily and a clindamycin lotion formulation (Dalacin T Rm) applied twice daily in the topical treatment of acne vulgaris. British Journal of Dermatology 143: 498–505, Sep 2000

    Article  PubMed  CAS  Google Scholar 

  9. Yaroshinsky A, Leyden J. The safety and efficacy of clindamycin [1% as clindamycin phosphate and tretinoin (0.025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe. Journal of the American Academy of Dermatology 50 (Suppl.): 23 (plus poster) abstr. P89, No. 3, Mar 2004

    Article  Google Scholar 

  10. Leyden J, Yaroshinsky A, Krochmal L. Tolerability assessment of combination clindamycin/tretinoin hydrogel for the treatment of acne vulgaris in 2219 subjects. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 25, No. 3, Mar 2005

    Google Scholar 

  11. Krochmal L, Yaroshinsky A. The novel combination clindamycin/tretinoin hydrogel: a randomized, double-blind, active- and vehicle-controlled study. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 23 (+ poster), No. 3, Mar 2005

    Google Scholar 

  12. Yaroshinsky A, Krochmal L. Acne treatment outcomes with a once-daily combination of clindamycin and tretinoin in hydrogel compared with single agents. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 26 (plus poster) abstr. P163, No. 3, Mar 2005

    Google Scholar 

  13. Leyden J, Yaroshinsky A, Krochmal L. Two randomized, controlled trials of a combination clindamycin/tretinoin hydrogel, compared with each agent alone for the tratment of acne vulgaris in 2219 subjects. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 25 (plus poster), No. 3, Mar 2005

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clindamycin/Tretinoin. Drugs R D 6, 231–234 (2005). https://doi.org/10.2165/00126839-200506040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200506040-00006

Keywords

Search

Navigation